PIA
MYOK

Piedmont Investment Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Piedmont Investment Advisors’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-530
Closed -$26K – 2694
2018
Q2 		$26K Buy
+530
New +$25.7K ﹤0.01% 1509

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Piedmont Investment Advisors's MYOK Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2018, closing a stake of 530 shares — an estimated $26K sold.

Piedmont Investment Advisors first reported a position in MYOK in Q2 2018 and held it in 1 quarter. The position peaked at $26K in Q2 2018. 125 funds tracked by Wall St. Rank hold MYOK as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 530 MyoKardia, Inc. Common Stock shares in Q3 2018, an estimated $26K.
  • Piedmont Investment Advisors first reported a position in MyoKardia, Inc. Common Stock in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's MyoKardia, Inc. Common Stock position peaked at $26K in Q2 2018.
  • 125 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.